MAFB and cervical cancer: Some studies demonstrated that this miRNA protects against the progression of diseases such as cervical cancer by targeting phosphoinositide-dependent protein kinase 1 (PDK1) [13] or type-2-diabetes by targeting the transcription factor MafB (Mafb) [14].